Vimarsana
Biggest News Aggregation in the World

Page 3 - Mark Crossley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Crossley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Crossley Today - Breaking & Trending Today

Indivior boss brings promise of a pick-me-up for staff - Vimarsana News

Indivior boss brings promise of a pick-me-up for staff

The chief executive of Indivior, the FTSE 250 addiction specialist, flew into London last week for a brief visit, including to catch up with employees at the group’s UK office in Slough.Staff at the

Indivior plans up to USD100 million share buyback programme - Vimarsana News

Indivior plans up to USD100 million share buyback programme

Indivior PLC on Friday announced a new share buyback programme, as it hailed its outlook for medium-term profitable growth. The Chesterfield, Virginia-headquartered pharmaceutical maker said the...

Nova Cannabis Indivior NewLake Capital Partners Q3 2023 Cannabis Earnings - Indivior (NASDAQ:INDV), Nova Cannabis (OTC:NVACF) - Vimarsana News

Nova Cannabis Indivior NewLake Capital Partners Q3 2023 Cannabis Earnings - Indivior (NASDAQ:INDV), Nova Cannabis (OTC:NVACF)

Nova Cannabis Inc. Reports Record Q3 2023 Revenue, Achieving Gross Margin Growth Nova Cannabis Inc. (TSX: NOVC) (OTCQB: NVACF) released its unaudited condensed interim consolidated financial statements for the three and nine months ended September 30, 2023. 

Indivior Announces Q3 2023 Financial Results - Vimarsana News

Indivior Announces Q3 2023 Financial Results

SLOUGH, United Kingdom and RICHMOND, Va., Nov. 9, 2023 /PRNewswire/ -- Indivior PLC today announced its financial results for the period ending September 30, 2023. The earnings release, investor...

US orders opioid overdose antidote to defend against Fentanyl terrorism | Cailley LaPara and Riley Griffin - Vimarsana News

US orders opioid overdose antidote to defend against Fentanyl terrorism | Cailley LaPara and Riley Griffin

Drugmaker Indivior Plc clinched a US contract worth up to $111 million for its opioid antidote—part of the government’s preparation for a potential bioterrorism attack with drugs such as fentanyl that can be released into the air.  The contract will secure US supplies of Opvee, an opioid reversal medication that…